appointments

R&D

Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia

Sales & Marketing

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Digital

The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.

R&D

In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.

News

Jennifer Taubert will hand over the reins of Johnson & Johnson's Innovative Medicines division to Tom Cavanaugh after she retires on 1st September.

News

After nearly a decade in the role, Guido Oelkers is stepping down as chief executive of Sobi to take the top job at BioNTech.